The global angiography devices market is estimated to reach $27,776 million in 2019, at a CAGR of 4.4% from 2014 to 2019. The growing demand of innovative digital flat-panel detectors, CT & MRA devices and launch of new products based on innovative technology, increasing aging population and prevalence of disease and rising awareness about the benefits of early diagnosis and treatment of cardiovascular diseases are the major factors driving the growth of the angiography devices market.
The angiography devices market is witnessing a gradual shift towards the magnetic resonance imaging from conventional x-ray angiography for diagnostics. Such products offer vascular imaging through noninvasive method with the help of magnetic fields and radio waves, completely eliminating the risk of X-ray exposure to patients and physicians. However, the high costs of angiography systems, and the lack of reimbursement are some of the major factors that could hinder the growth of this market to a certain extent.
The angiography devices market studied in this report is mainly segmented by technology, products, application, procedure, indication and end users. Based on products the market is further segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. On the basis of technology the market is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented into diagnostics and therapeutic. Based on indication, the market is segmented as known/suspected CAD, valvular heart disease, congenital heart disease, and congenital heart failure. Based on procedure, the market is segmented as coronary angiography, micro-angiography, neuro-vascular, peripheral angiography, post-mortem CT angiography, and other procedures (radiofrequency tumor ablation studies, other RF procedures). The market, by end users, is divided into hospitals, diagnostic centers, and academic research laboratories.
The global angiography devices market is dominated by North America, followed by Europe. However, the Asian market is expected to witness the highest growth due to increasing procedure volumes (caused by huge aging population and rising number of patients with cardiovascular disease symptoms). North America and Europe are expected to grow at a sluggish rate since these are relatively saturated markets. These markets will be driven by the trend of replacing old devices with newer, advanced ones.
Prominent players in this market are Siemens Healthcare (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Royal Philips Electronics (Netherlands), St. Jude Medical, Inc. (U.S.), Abbott Vascular (Abbott Laboratories) (U.S.), Cordis Corporation (A JNJ Company) (U.S.), Boston Scientific Corporation (U.S.), and Medtronic, Inc. (U.S.).
Comments
Post a Comment